<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
Commission File Number 0-27456
--------
NOTIFICATION OF LATE FILING
(Check one): [X] Form 10-K and Form 10-KSB [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q and Form 10-QSB [ ] Form N-SAR
For Period Ended: December 31, 1997
------------------
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
- -----------------------------------------------
Read attached instruction sheet before preparing form. Please
print or type.
Nothing in this form shall be construed to imply that the commission
has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
PART I --REGISTRANT INFORMATION
Full name of registrant EquiMed, Inc.
-------------
Former name if applicable EquiVision, Inc.
----------------
Address of principal executive office (Street and number)
2171 Sandy Drive
- ----------------------------------------------------------------------------
City, State and Zip Code State College, PA 16803
------------------------
<PAGE> 2
PART II--RULES 12B-25 (B) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be
filed on or before the 15th calendar day following the prescribed
due date; or the subject quarterly report or transition report on
the From 10-Q, or portion thereof will be filed on or before the
fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III -- NARRATIVE
State below in reasonable detail the reasons why Form 10-K and Form 10-KSB,
11- K, 20-F, 10-Q and Form 10-QSB, N-SAR or the transition report or portion
thereof could not be filed within the prescribed time period. (Attach extra
sheets if needed.)
In 1997 the Registrant consummated the acquisition of a number of
administrative services and support entities, several of which are located
overseas. Due to logistic difficulties in consolidating and auditing certain
accounting records, particularly records pertaining to the overseas
operations, Registrant was unable to complete its financial statements for the
period ended December 31, 1997 in a timely fashion.
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
modification
Daniel Beckett (814) 238-0375
-----------------------------------------------------
(Name) Area Code Telephone Number
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
file such report(s) been filed? If the answer is period that the
registrant was required to no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
<PAGE> 3
EquiMed, Inc.
- ------------------------------------------------------------------------
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the
unsigned thereunto duly authorized.
Date March 31, 1998 By /S/ DANIEL L. BECKETT
----------------- ----------------------------
Daniel L. Beckett
Chief Financial Officer
Instruction: The form may be signed by an executive officer of
the registrant or by any other duly authorized representative. The
name and title of the person signing the form shall be typed or
printed beneath the signature. If the statement is signed on behalf of
the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign
on behalf of the registrant shall be filed with the form.
